Sunshine Biopharma Inc.: Form 8-K/A, filed Dec 12, 2022
Filed with the SEC on Dec 12, 2022 and accepted by EDGAR at Dec 12, 2022, 16:31 ET.
Items reported
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001683168-22-008357. Last ingested by Listed: Nov 11, 2026, 03:50 ET. Listed shows no prices and gives no investment advice.